Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Cholangiocarcinoma × Hepatectomy × Clear all

Phase

Phase NA 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Hepatocellular 12 Recurrence 3 Liver Neoplasms 3 Colorectal Neoplasms 3 Secondary Malignant Neoplasm of Liver 1 Reperfusion Injury 1 Postoperative Complications 1 Obesity, Morbid 1 Neoplasm Metastasis 1 Nasopharyngeal Carcinoma 1 Metabolic Syndrome 1 Klatskin Tumor 1 Disease Progression 1 Cholangiocarcinoma 1 Abdominal Injuries 1

Interventions

Radiofrequency Ablation 8 Liver Transplantation 5 Stents 4 Radiotherapy 2 Electroporation 2 Cholangiopancreatography, Endoscopic Retrograde 2 1-phenyl-3,3-dimethyltriazene 2 maltodextrin 1 camrelizumab 1 apatinib 1 X-Rays 1 Therapeutic Irrigation 1 Technetium Tc 99m Sulfur Colloid 1 Surveys and Questionnaires 1 Surgical Procedures, Operative 1 Sodium Chloride 1 S 1 (combination) 1 Resistance Training 1 Radionuclide Imaging 1 Quality of Life 1 Proton Therapy 1 Photons 1 Photochemotherapy 1 Pancreatectomy 1 Nuclear Receptor Subfamily 4, Group A, Member 3 1 Microspheres 1 Lymph Node Excision 1 Immunotherapy, Active 1 Hepatectomy 1 Hematoporphyrins 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02232932 2021-11-03

TRANSPHIL

Assistance Publique - Hôpitaux de Paris

Phase NA Unknown

Gastrointestinal

Cholangiocarcinoma, Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡